Survival for head and neck squamous cell carcinoma treated with versus without neoadjuvant systemic therapy: A national propensity score–matched analysis.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.6035
Abstract: 6035 Background: Neoadjuvant systemic therapies, including immunotherapy and chemotherapy, offer a promising approach for treating head and neck squamous cell carcinoma (HNSCC). These therapies aim to reduce tumor burden and enable personalized treatment. While pivotal… read more here.
Keywords: without neoadjuvant; therapy; head neck; immunotherapy ... See more keywords